Clinical trial
Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT00176878 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00176878 |
|---|---|
| Title | Stem Cell Transplant for Bone Marrow Failure Syndromes |
| Official title | Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diamond-Blackfan Anemia, Kostmann's Neutropenia, Shwachman-Diamond Syndrome |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Stem cell transplant, Fludarabine monophosphate, Total lymphoid irradiation, Busulfan, anti-thymocyte globulin |
| Enrollment | 10 |
| Start date | Jun 1, 2000 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: